{
    "id": "wrong_mix_domain_foundationPlace_00114_1",
    "rank": 90,
    "data": {
        "url": "https://www.cff.org/researchers/academic-funding-opportunities",
        "read_more_link": "",
        "language": "en",
        "title": "Academic Funding Opportunities",
        "top_image": "https://www.cff.org/modules/custom/cff_core/images/logo-og.jpg",
        "meta_img": "https://www.cff.org/modules/custom/cff_core/images/logo-og.jpg",
        "images": [
            "https://www.cff.org/themes/custom/outline_frontend/logo.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "We offer awards for cystic fibrosis research and for professional development and training. Below is a list of current and upcoming funding opportunities.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/outline_frontend/favicon.ico",
        "meta_site_name": "Cystic Fibrosis Foundation",
        "canonical_link": "https://www.cff.org/researchers/academic-funding-opportunities",
        "text": "Purpose: To provide the opportunity for clinically trained physicians to identify and study interventions to enhance successful self-management and related health outcomes among individuals with CF.\n\nFunding: Up to $21,000 in direct costs plus 12% of indirect costs ($23,520 total costs) per year\n\nDuration: Up to three years\n\nDeadline: March\n\nPurpose: To provide resources and planning support for proposed multi-center clinical trials that address a TIME area of interest and have the potential to result in meaningful changes to the current treatment paradigm.\n\nFunding: Up to $125,000 per year, plus an additional 12% indirect costs\n\nDuration: One year\n\nDeadline: January 2024\n\nPurpose: To use innovative registry-based analyses that aim to test novel methods to advance the use of the Foundation's Patient Registry.\n\nFunding: Up to $150,000 per year for up to two years, plus an additional 12% indirect costs.\n\nDuration: Two years\n\nDeadlines: Letter of Intent: August 9, 2023; full application: November 14, 2023\n\nPurpose: To provide support for multi-investigator research projects that have the potential to make an important contribution to health equity in the CF population.\n\nFunding: Up to $200,000 per year for up to four years, plus an additional 12% indirect costs per year. The lead institution may request up to $50,000 in additional direct costs per year to support an administrative core.\n\nDuration: Four years\n\nDeadlines: LOI April 2024, full application September 2024\n\nPurpose: To provide support for multi-investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation’s mission.\n\nFunding: Each applicant may request up to $200,000 per year for up to three years + an additional 12% indirect costs per year; lead institution may request up to $25,000 in additional direct costs per year\n\nDuration: 3 years\n\nDeadlines: LOI April, full application August\n\nPurpose: To solicit and fund projects that will improve our understanding of the biological basis for the development and progression of gastrointestinal manifestations in cystic fibrosis as well as to identify potential novel therapeutic strategies to manage and treat them\n\nFunding: Up to $150,000 per year + up to 12% indirect costs\n\nDuration: 3 years\n\nDeadline: December\n\nPurpose: To facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches.\n\nFunding: May not exceed $1 million/year + 12% indirect costs\n\nDuration: 3 years\n\nDeadline: July\n\nPurpose: To provide bridge funding for CF-relevant R01 (or equivalent) applications that were submitted to NIH (or other governmental agencies) that scored in the 40th percentile but were not awarded by the funding agency.\n\nFunding: $125,000/year (indirect costs not allowed)\n\nDuration: Up to 2 years or until NIH funding is secured\n\nDeadline: Rolling\n\nPurpose: To introduce residents to research through participation in a CF-relevant research project with the goal to develop and maintain interest in a career in CF research or as a CF care provider.\n\nFunding: $10,000 for one year\n\nDuration: 1 year\n\nDeadline: November 15, 2023\n\nPurpose: To enable training in new research areas and methods to advance the scientific knowledge of the applicant and to collect data to enable their transition into an impactful research career.\n\nFunding: Up to $75,000 in the first year and up to $76,000 in the second year (indirect costs not allowed)\n\nDuration: 2 years\n\nDeadline: December\n\nPurpose: To support postdoctoral research fellows pursuing non-Path to a Cure related research during their fellowship and aid in their transition to an independent research faculty position.\n\nFunding: Up to $86,000 per year during the training phase of the award. The faculty phase includes $80,000 for salary support and $30,000 for research support. (Indirect costs not allowed.)\n\nDuration: 3 – 5 years\n\nDeadline: December\n\nPurpose: The intent of this program is to support fellowship programs that integrate CF care and mentorship early in their fellowship curriculum.\n\nFunding: $78,000, which includes up to $72,000 for salary and benefits and $2,000 each for travel and/or registration fees for three fellows to attend NACFC\n\nDuration: One year\n\nDeadline: September 2024\n\nPurpose: To encourage outstanding newly trained internists and pediatricians to enhance clinical proficiency in CF-related subspecialties and to develop the necessary research capabilities to become independent biomedical investigators.\n\nFunding: Ranges from $65,000 stipend plus $11,000 research and development for first year to $100,000 stipend plus $31,000 research and development for sixth year (indirect costs not allowed)\n\nDuration: 3-6 years\n\nDeadline: February\n\nPurpose: To enable promising early-career physician scientists seeking additional research mentoring outside of their home academic institutions to enhance their clinical or translational research proficiency and support their development of the necessary clinical research capabilities to become independent investigators.\n\nFunding: Up to $42,420 per year\n\nDuration: 3 years\n\nDeadline: May\n\nPurpose: To support excellent CF-focused researchers whose projects have been submitted to and approved by the NIH but cannot be supported by available funds.\n\nFunding: $80,000 per year (indirect costs not allowed)\n\nDuration: Up to 2 years or until NIH funding is secured\n\nDeadline: January 1 to November 3\n\nPurpose: To provide supplemental funding to qualified and promising scientists early in their faculty careers who have obtained K funding from the National Institutes of Health in areas that reflect the Cystic Fibrosis Foundation's research priorities.\n\nFunding: $50,000 (indirect costs not allowed)\n\nDuration: Up to 5 years/duration of the NIH K-award\n\nDeadline: Rolling\n\nPurpose: To enable outstanding early career pediatricians and internists to enhance their clinical research proficiency and to develop the necessary clinical research capabilities to become independent investigators who formulate and lead multi-center, clinical research studies.\n\nFunding: Up to $40,740 per year (plus travel)\n\nDuration: 3 years\n\nDeadlines: LOI March, full application June\n\nPurpose: This award will promote greater collaborative integration of statisticians and CF clinical investigators at TDN institutions by funding local statisticians and integrating them into the CF Statistical Research Network (CF StatNet).\n\nFunding: Year 1, 35% FTE; Year 2, 25% FTE; Year 3, 20% FTE\n\nDuration: Three years\n\nDeadline: LOI August 2024, full application December 2024\n\nPurpose: For research projects that aim to use available clinical trials in organ transplantation specimens and/or clinical data to improve knowledge of chronic lung allograft dysfunction (CLAD) pathogenesis and explore new approaches to detection, prevention, monitoring, or treatment of CLAD.\n\nFunding: Between $50,000 to $100,000 per year for up to two years plus 12% indirect costs\n\nDuration: 2 years\n\nDeadlines: LOI: June 13, 2024; Full application: September 12, 2024\n\nPurpose: For research projects that aim to identify biomarkers, improve knowledge of pathogenesis, and explore new approaches to treatment of chronic lung allograft dysfunction (CLAD).\n\nFunding: Up to $150,000 per year for up to two years, plus an additional 12% indirect costs for independent research; and up to $350,000 per year for up to two years, plus 12% indirect costs for collaborative research.\n\nDuration: 2 years\n\nDeadlines: LOI: May 21, 2024; Full application: August 15, 2024\n\nPurpose: Quality improvement (QI) awards for projects designed to improve the early diagnosis of CF through the newborn screening system and/or to improve the initial management of infants with positive screening tests and the follow-up communications with their families.\n\nFunding: $75,000 per year for 2 years (plus 12% indirect costs)\n\nDuration: 2 years\n\nDeadline: July"
    }
}